89 related articles for article (PubMed ID: 7909855)
21. [In situ hybridization study on the localization of HPV DNA in the precancerous lesions of uterine cervix].
Nagai N; Kioka H; Shigemasa K; Fujiwara A
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):313-20. PubMed ID: 2543717
[TBL] [Abstract][Full Text] [Related]
22. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
23. [Immunohistochemical examination oncogenic c-erb-b2, egf-r proteins and antioncogenic p53 protein in vulvar cancers HPV-16 positive and negative].
Kedzia W; Goździcka-Józefiak A; Kedzia H; Spaczyński M
Ginekol Pol; 2000 Feb; 71(2):63-9. PubMed ID: 10765601
[TBL] [Abstract][Full Text] [Related]
24. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
25. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
26. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix.
Soufla G; Baritaki S; Sifakis S; Zafiropoulos A; Spandidos DA
Int J Biol Markers; 2005; 20(1):18-27. PubMed ID: 15832769
[TBL] [Abstract][Full Text] [Related]
28. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
29. Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.
Ueno S; Sudo T; Oka N; Wakahashi S; Yamaguchi S; Fujiwara K; Mikami Y; Nishimura R
Int J Gynecol Cancer; 2013 Jul; 23(6):1084-91. PubMed ID: 23792604
[TBL] [Abstract][Full Text] [Related]
30. Detection of human papillomavirus DNA, serum p53, and p53 antibodies in patients with cervical cancer.
Sobti RC; Parashar K; Kaur R; Capalash N
J Environ Pathol Toxicol Oncol; 2002; 21(1):79-85. PubMed ID: 11934017
[TBL] [Abstract][Full Text] [Related]
31. [The detection of p53 gene and HPV16 oncogene in cervical carcinoma].
Sun Y; Si L
Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):29-32. PubMed ID: 7781112
[TBL] [Abstract][Full Text] [Related]
32. The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells.
Chen TM; Chen CA; Hsieh CY; Chang DY; Chen YH; Defendi V
Oncogene; 1993 Jun; 8(6):1511-8. PubMed ID: 8389030
[TBL] [Abstract][Full Text] [Related]
33. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin.
Prusty BK; Das BC
Int J Cancer; 2005 Mar; 113(6):951-60. PubMed ID: 15514944
[TBL] [Abstract][Full Text] [Related]
34. Newly established uterine cervical carcinoma cell line with co-amplification of human papillomavirus DNA and c-myc gene.
Gotoh M; Nakajima T; Yokota J; Tsunokawa Y; Terada M; Shimoyama Y; Teshima S; Hirohashi S; Shimosato Y
Jpn J Cancer Res; 1991 Nov; 82(11):1252-7. PubMed ID: 1721614
[TBL] [Abstract][Full Text] [Related]
35. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
36. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
Kaufmann AM; Backsch C; Schneider A; Dürst M
Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
[TBL] [Abstract][Full Text] [Related]
37. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions.
Das BC; Sharma JK; Gopalakrishna V; Luthra UK
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2327-36. PubMed ID: 1328489
[TBL] [Abstract][Full Text] [Related]
38. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
39. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma.
Ferber MJ; Thorland EC; Brink AA; Rapp AK; Phillips LA; McGovern R; Gostout BS; Cheung TH; Chung TK; Fu WY; Smith DI
Oncogene; 2003 Oct; 22(46):7233-42. PubMed ID: 14562053
[TBL] [Abstract][Full Text] [Related]
40. Detection of human papillomavirus type 16 DNA and evidence for integration into the cell DNA in cervical dysplasia.
Shirasawa H; Tomita Y; Kubota K; Kasai T; Sekiya S; Takamizawa H; Simizu B
J Gen Virol; 1986 Sep; 67 ( Pt 9)():2011-5. PubMed ID: 3018133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
